Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

ATHA Stock Annual Income Statement. Download in Excel

Athira Pharma Inc. logo

Athira Pharma Inc.

Sector: Manufacturing   

Industry: Biological Product (except Diagnostic) Manufacturing

0.23
 
USD
  
-0.01
  
(-3.38%)
Previous close: 0.237  Open: 0.237  Bid: 0.2265  Ask: 0.229
52 week range    
0.22   
   3.67
Mkt Cap: 9 M  Avg Vol (90 Days): 206,066
Last updated: Thursday 17th April 2025

Stock Rankings

46
MarketXLS Rank
80
Value
36
Technical
23
Quality
How are these ranks calculated?
Search for a stock

Financials

ATHA Income Statement

Annual
Invalid dateDec-20Dec-21Dec-22Dec-23Dec-24
Basic EPS from continuing operations-1.67-1.49-2.53-3.09-2.52
Basic EPS total-1.67-1.49-2.53-3.09-2.52
Basic weighted shares outstanding12 M37 M38 M38 M38 M
Depreciation2000.0479000.0845000.0969000.0970000.0
DepreciationAndAmortization2000.0479000.0845000.0969000.0970000.0
Diluted EPS total-1.67-1.49-2.53-3.09-2.52
Diluted normalized net income/share-2.53-3.09-2.52
Diluted weighted shares outstanding12 M37 M38 M38 M38 M
GeneralAndAdministrativeExpense7 M21 M33 M33 M26 M
Income before tax-21 M-64 M-96 M-118 M-97 M
Income restructuring and M&A3 M
Interest income124000.0337000.0
InterestExpenseNonOperating367000.03000.0
MiscOtherSpecialCharges-1 M334000.03 M8 M4 M
Net income from total operations-20 M-55 M-96 M-118 M-97 M
NetIncomeCommonStockholders-20 M-55 M-96 M-118 M-97 M
NetIncomeContinuousOperations-20 M-55 M-96 M-118 M-97 M
NetIncomeFromOtherGainsLosses1 M9 M5 M
NetNonOperatingInterestIncomeExpense-243000.0334000.0
NonRecurringOperationExpense10 M-2 M4 M
Normalized income-89 M
Operating income-20 M-64 M-104 M-125 M-101 M
Operating income before depreciation (EBITDA)-20 M-55 M-88 M-116 M-96 M
OperatingExpense20 M64 M89 M127 M97 M
Other income net1 M-334000.0-7 M-8 M-4 M
OtherGandA7 M21 M33 M33 M26 M
OtherOperatingExpenses85000.0323000.0-684000.0-2 M-1 M
Research & development expense13 M43 M61 M94 M71 M
ResearchExpense13 M43 M61 M94 M71 M
RestructringAndMnAIncome3 M
SalariesAndWages11 M11 M
Selling Gen & administrative expense7 M21 M33 M33 M26 M
Special income/charges-10 M2 M-4 M
Total Income available for interest expense (EBIT)-20 M-55 M-89 M-118 M-97 M
Total common shares outstanding37 M38 M38 M38 M39 M
Total net income-20 M-55 M-96 M-118 M-97 M
Total ordinary shares39 M39 M39 M39 M39 M
TotalExpenses20 M64 M89 M127 M97 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader